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Abstract
Background: Current malaria control strategies recommend (i) early case detection using rapid diagnostic tests
(RDT) and treatment with artemisinin combination therapy (ACT), (ii) pre-referral rectal artesunate, (iii) intermittent
preventive treatment and (iv) impregnated bed nets. However, these individual malaria control interventions
provide only partial protection in most epidemiological situations. Therefore, there is a need to investigate the
potential benefits of integrating several malaria interventions to reduce malaria prevalence and morbidity.
Methods: A randomized controlled trial was carried out to assess the impact of combining seasonal intermittent
preventive treatment in children (IPTc) with home-based management of malaria (HMM) by community health
workers (CHWs) in Senegal. Eight CHWs in eight villages covered by the Bonconto health post, (South Eastern part
of Senegal) were trained to diagnose malaria using RDT, provide prompt treatment with artemether-lumefantrine
for uncomplicated malaria cases and pre-referral rectal artesunate for complicated malaria occurring in children
under 10 years. Four CHWs were randomized to also administer monthly IPTc as single dose of sulphadoxine-
pyrimethamine (SP) plus three doses of amodiaquine (AQ) in the malaria transmission season, October and
November 2010. Primary end point was incidence of single episode of malaria attacks over 8 weeks of follow up.
Secondary end points included prevalence of malaria parasitaemia, and prevalence of anaemia at the end of the
transmission season. Primary analysis was by intention to treat. The study protocol was approved by the
Senegalese National Ethical Committee (approval 0027/MSP/DS/CNRS, 18/03/2010).
Results: A total of 1,000 children were enrolled. The incidence of malaria episodes was 7.1/100 child months at risk
[95% CI (3.7-13.7)] in communities with IPTc + HMM compared to 35.6/100 child months at risk [95% CI (26.7-47.4)]
in communities with only HMM (aOR = 0.20; 95% CI 0.09-0.41; p = 0.04). At the end of the transmission season,
malaria parasitaemia prevalence was lower in communities with IPTc + HMM (2.05% versus 4.6% p = 0.03).
Adjusted for age groups, sex, Plasmodium falciparum carriage and prevalence of malnutrition, IPTc + HMM showed
a significant protective effect against anaemia (aOR = 0.59; 95% CI 0.42-0.82; p = 0.02).
Conclusion: Combining IPTc and HMM can provide significant additional benefit in preventing clinical episodes of
malaria as well as anaemia among children in Senegal.
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Malaria remains a major public health problem in tropi-
cal regions. According to the World Health Organiza-
tion (WHO), in 2009 there were an estimated 169-294
million cases and 628,000-968,000 deaths worldwide.
Over 89% of these deaths occur in Africa [1], most of
the time outside health facilities [2,3]. In view of this
situation, there is need to strengthen malaria case man-
agement and malaria prevention at the community level
to reduce the burden of disease. Recently, the WHO
advocated for scaling up malaria control interventions in
order to accelerate malaria elimination [4] Several
malaria control strategies were developed recently,
including (i) early case detection using rapid diagnostic
tests (RDT), prompt treatment with effective anti-malar-
ial drugs, such as artemisinin combination therapy
(ACT) for uncomplicated malaria cases, (ii) pre-referral
rectal artesunate for severe malaria cases, (iii) intermit-
tent preventive treatment, and( i v )l o n g - l a s t i n gi n s e c t i -
cide-treated nets (LLIN).
Effective case management is a fundamental element
of malaria control. To improve treatment practices at
community level, the strategy of home-based manage-
ment of malaria (HMM) has been developed [5,6].
Home-based management of malaria (HMM) is now
considered as an important strategy for reducing severe
morbidity and mortality from malaria in resource-poor
countries [7,8].
In Senegal, the National Malaria Control Programme
(NMCP) has initiated the scaling up of the use of ACT
at community level, in the context of HMM strategy,
implemented by community health workers (CHWs) in
order to strengthen malaria control efforts. This strategy
includes the use of RDT for malaria confirmation and
ACT for the treatment of uncomplicated malaria.
Intermittent preventive treatment (IPT) is a new
approach aiming at reducing malaria morbidity among
children or other high-risk individuals. IPT involves
administration of anti-malarial drugs at defined time
intervals to individuals regardless of whether they are
known to be infected with malaria to prevent morbidity
and mortality from the infection [9]. IPT was initially
recommended for pregnant women involving the
administration of at least two doses of sulphadoxine-
pyrimethamine (SP) during antenatal visits after the first
trimester of pregnancy. More recently the strategy was
extended to infants (IPTi) with the administration of
three doses of an anti-malarial drug during the
expanded programme of immunization (EPI) visits [10].
In children under 5 years of age, several studies have
shown IPT to be effective in reducing malaria burden
[11,12]. Intermittent preventive treatment of malaria in
children less than 5 years of age (IPTc), involves the
administration of two to three doses of anti-malarial
drug during the high malaria transmission season [13].
Cissé et al. during a randomized double-blind con-
trolled trial, conducted in Niakhar in Senegal have
shown that administering SP plus artesunate three times
during the transmission season can reduce malaria inci-
dence among children under 5 years by 86% [11]. Pro-
tective efficacy of IPTc in Mali was estimated at 67.5%
with two doses of SP at 8 weeks intervals during the
high malaria transmission season [12]. Another study
conducted in the rural area of Niakhar (Senegal)
demonstrated that the most optimal regimen for IPTc
in children is the combination of SP-amodiaquine. To
ensure a maximum protective effect, the IPTc should
preferably combine two long half-life drugs [14].
In most African countries, anti-malarial interventions
are being promoted on an individual basis and many
communities are still not getting access to those services
[15]. In 2008, it was estimated by WHO that confirma-
tion of malaria cases was done in only 22% on average
in most African regions, while less than 15% of patients
under 5 years of age suffering from malaria attacks ben-
efitted from treatment with ACT. It thus appears that
the use of effective malaria control strategies and their
integration into national health systems and services
continue to be a challenge in Africa [1]. In addition,
individual anti-malarial interventions provide only par-
tial protection in most epidemiological situations
[16,17]. Therefore, there is a need to investigate the
potential benefits of integrating several malaria interven-
tions, in reducing malaria prevalence and morbidity.
This study aimed to assess the impact of combining sea-
sonal intermittent preventive treatment in children
(IPTc) with home-based management of malaria
(HMM) by community health workers (CHWs) in
Senegal.
Methods
Study area and population
The study was carried out at the Bonconto health post,
located at the Velingara health district in the south-east-
ern part of Senegal, 500 km from the capital city of
Dakar. The health post is headed by a nurse and has
eight functional health huts staffed with community
health workers, serving a total population of 10,016
inhabitants. In this area malaria transmission is seasonal,
occurring during the rainy season (July to November)
with a peak transmission in October and November.
Plasmodium falciparum is the predominant parasite
species and transmission is mainly due to Anopheles
gambiae s.l. (Konate Lassana, personal communication).
In this area, the National Malaria Control Programme
initiated the universal coverage of LLIN strategy in 2010.
Tine et al. Malaria Journal 2011, 10:358
http://www.malariajournal.com/content/10/1/358
Page 2 of 9Study design
The study was designed as a cluster randomized trial.
Eight CHWs in the eight villages around the Bonconto
health post, were trained to diagnose malaria using RDT
and provide prompt treatment with artemether-lumefan-
trine to children less than 10 years. Four of them were
randomized to also administer monthly IPTc with single
dose of SP plus three doses of amodiaquine (AQ) in
October and November 2010. The randomization unit
was the CHW in order to avoid contamination. Each
CHW is covering one village. The CHWs were rando-
mized using a random number generator from Excel
software.
Primary end point was incidence of single or first
malaria attack over 8 weeks of follow up throughout an
active surveillance system. Malaria attack was defined as
presence of fever (temperature > 37.5°C) with a positive
RDT. Secondary end points were prevalence of malaria
at the end of the transmission season, and prevalence of
anaemia at the end of the transmission season in the
two groups.
Interventions
The two main interventions in this study were HMM
and IPTc for children aged from one to 10 years. During
the study period, RDT were deployed at the level of
health huts. The RDT used in this study was based on
the detection of the Histidine Rich Protein II (Malaria
Antigen P.f SD
®), and was provided by the NMCP.
For uncomplicated malaria cases, treatment was done
by CHWs using artemether-lumefantrine according to
age group; children presenting severe malaria cases
received one dose (10 mg/kg) administration of pre-
referral artesunate suppositories prior to their transfer
to the Bonconto health post. In the four villages with
combined HMM and IPTc, all doses of AQ and SP were
administered by CHWs under direct observation. IPTc
drug delivery was organized at the level of health huts.
At scheduled days for IPTc administration, parents were
asked to bring their child at the health huts for IPTc
delivery. In case a child was not seen at time of adminis-
tration, the CHW was advised to visit that child at home
and give the treatment. To facilitate SP and AQ admin-
istration, treatment doses were tabulated on a document
and distributed to each CHW to serve as job aid.
Each tablet of AQ contains 153 mg of amodiaquine
base while SP tablet contains 500 mg sulphadoxine and
25 mg pyrimethamine. Treatment doses were according
to age group. Children under 2 years of age received
half a tablet of SP; a whole tablet of SP was given to
children age from two to 6 years, while children age
from seven to 10 years received one tablet and half of
SP. For AQ half a tablet was given to children under 2
years, one tablet and one and a half tablet were given
daily for 3 days to children aged 2-7 years and 8-10
years respectively. This drug regimen has been shown to
be the most optimal regimen to minimize overdosing as
well as under dosing of AQ [18].
Artemether-lumefantrine (Novartis
LTD) was provided
by the Senegalese NMCP, rectal artesunate was obtained
from Mepha
Ltd, while AQ and SP were provided by
Kina Pharm
Ltd.
Data collection
Baseline assessment
Prior to start of the study, meetings were held in the vil-
lages to explain the study purpose and answer to the
population’s questions. Consent was obtained from the
community leaders as well as parents or children’s guar-
dians. A census of all children aged from one to 10
years leaving in each randomized village was done. A
baseline assessment was done prior to the intervention
(beginning of October). At baseline, all registered chil-
dren were examined by a study physician, and their
mothers interviewed to assess the use of bed nets, and
the presence of any chronic illness which might interfere
with the outcome of the trial. Thick and thin blood
films were prepared and haemoglobin concentration
measured using HemoCue Hb 201
®. Children with
acute malaria during the baseline study (temperature >
37.5°C and positive RDT) were treated with artemether-
lumefantrine and those with anaemia (Hb < 11 g/dl)
received oral iron supplementation for 1 month.
Malaria cases detection
An active surveillance system was organized in the eight
villages from the date of first IPTc administration, to the
end of the transmission season in December. Children
w e r ev i s i t e da th o m eb yC H Wo n c eaw e e kd u r i n g8
weeks. At each visit children’s axillary temperature was
measured. If the child had fever (temperature > 37.5°C),
or a history of fever within the previous 24 h, a RDT was
performed by the CHW. Children with acute malaria
(temperature > 37.5°C and positive RDT) received a
three-day treatment with artemether-lumefantrine. A fol-
low-up was done by the CHWs up to day seven after
treatment, to monitor the patient’s clinical conditions. In
case the child did not recover on day 3, CHWs were
advised to refer the child to the health post. The mothers
were encouraged to take their child to the CHWs if the
child presented fever in non-scheduled days visits.
Malaria parasitaemia and anaemia prevalence evaluation
A cross-sectional survey was carried out at the end of
the malaria transmission season in a subsample of study
participants, randomly selected from the list of children
less than 10 years living in the eight villages. For each
randomly selected child, thick and thin smear test were
done, haemoglobin (Hb) concentration measured and
anthropometric data collected.
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With four clusters in each intervention arm and 125
children less than 10 years sampled in each cluster,
assuming a current incidence of malaria attacks of 35
per 100 person-month at risk, the study was powered at
80% to detect 20% of reduction of malaria incidence in
the HMM + IPTc group at 5% significance level, with a
coefficient of variation of 0.3. For the cross sectional
survey the total number of children to examine was cal-
culated at 800, based on a prevalence of malaria parasi-
taemia at 20% in the study area (Senegal MIS 2009) a
confidence level at 95% with a precision of 5%, power
level at 90% and assuming a percentage of 20% of
withdrawal.
Laboratory methods
Blood samples were collected using finger prick blood.
The first drop was used for thick and thin smear test
for the diagnosis of malaria. Thick and thin smear test
were stained with Giemsa and read by a laboratory tech-
nician. Malaria parasitaemia was defined as any asexual
parasitaemia detected on a thick or thin blood smear.
Parasite density was determined by counting the num-
ber of asexual parasites per 200 white blood cells, and
calculated per μL using the following formula: num-
bered parasites × 8,000/200 assuming a white blood cell
count of 8,000 cells per μL. Absence of malaria parasite
in 200 high power ocular fields of the thick film was
considered as negative.
The second drop of finger prick blood was drawn into
a microcuvette for Hb determination (g/dl) using Hemo-
C u em a c h i n e( H e m o C u e
® Hb 201). Moderate and
severe anaemia were defined as Hb concentration below
11 g/dl and 8 g/dl, respectively.
Data analysis and data management
Data were entered in Excel™ software and analysed
using STATA 11™ software. For descriptive data, per-
centage was used to assess the frequency of each out-
come. For quantitative data, mean and standard
deviation were used to describe normally distributed
variables, median and range for other data. Characteris-
tics of all children included in the study were tabulated
by study arm.
For the primary end point of incidence of malaria
attacks over 8 weeks of follow up, analysis was by inten-
tion to treat including all children who attended the
baseline survey. For the secondary end points of cross
sectional prevalence of malaria and anaemia at the end
of the transmission season, analysis was done by per
protocol, including all children seen at cross sectional
survey at the end of the transmission season.
To assess the impact of combining HMM + IPTc,
analysis was conducted at the individual level with
adjustment for clustering using robust standard errors
[19]. Time at risk was calculated from date of the first
IPTc administration to the date of the cross-sectional
survey. Children were not considered at risk for 28 days
after treatment for malaria attacks, and thus were cen-
sored from the analysis for 4 weeks, although no child
presented more than one malaria episode. Time at risk
to the first malaria episode between the two study arms
was compared using Kaplan Meier method with a log
rank test stratified by clusters. The incidence rate ratio
(IRR) of HMM + IPTC and HMM alone was deter-
mined after adjustment by age group and gender using
Cox regression model with robust standard errors to
account for clustering. The protective efficacy of HMM
+ IPTc on malaria incidence was calculated as (1-IRR) ×
100. P values below 5% were considered as significant
(two sided). Prevalence of malaria parasitaemia and
anaemia at the end of the transmission season were
measured in the two groups and compared using a
logistic regression analysis with robust standard errors
to take into account for the cluster design.
Ethical considerations
Prior to the study, a community sensitization was
undertaken and community consent was obtained from
community leaders (religious guide, village head).
Informed consent was obtained from parents or chil-
dren’s guardians the days of surveys. The study protocol
was approved by the Senegalese National Ethical Com-
mittee (Conseil National de Recherche en Santé).
Approval N 027/MSP/DS/CNRS, 18/03/2010.
Results
Baseline characteristics
One thousand and twenty children aged from 1 to 10 years
were registered in the eight villages with functional health
huts, covered by the Bonconto health post; 1,000 children
(500 in the HMM group and 500 in the HMM + IPTc
group) who met the entry criteria were enrolled (Figure 1).
At baseline the two groups were similar in terms of
demographic characteristics (age, gender and P. falci-
parum carriage). Prevalence of moderate anaemia and
severe anaemia were similar in the two groups, as well
as prevalence of under nutrition (stunting, underweight);
95.8% of study subjects in the HMM + IPTc group and
95.4% in the HMM group slept under a LLIN (Table 1).
Impact of the interventions on malaria incidence
Overall, the cumulative incidence of malaria episodes
was significantly lower in the HMM + IPTc group.
Thus, the Kaplan Meier survival estimates of time to
f i r s tm a l a r i ae p i s o d es h o w e das i g n i f i c a n td i f f e r e n c e
between the two groups (p = 0.001, log rank test) (Fig-
ure 2).
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study period was 35.6 per 100 children-months at risk
in the HMM group while that for children in the HMM
+ IPTc group was only 7.2 per 100 children-month at
risk (p = 0.04). After controlling for age group, and gen-
der, the combination of IPTc + HMM significantly
reduced the number of malaria episodes in children:
adjusted incidence rate ratio: 0.21 (95% CI [0.10-0.42]);
p = 0.04. Thus, the protective efficacy of IPTc + HMM
against malaria attacks incidence (all cases) was 79%
(95% CI [58%-90%]) (Table 2). During the intervention
period, 5/510 children in the HMM group (0.98%) pre-
sented severe malaria, while no severe malaria cases
were noted in the HMM + IPTc group.
1020 children identified by census 
8 clusters defined in villages 
covered by Bonconto Health post 
Excluded  (n=10 ) 
♦Not meeting inclusion criteria (n= 05) 
♦Declined to participate (n= 05) 
Primary end point: Malaria Incidence  (n= 500) 
♦Secondary end points (n=413)
Completed 8 weeks follow up: (n=498) 
1Discontinued follow up:      (n=02 ) 
HMM                                       
4 clusters                              
510 children under 10 years 
Completed 8 weeks follow up: (n=497)       
2Discontinued follow up:  (n=03 ) 
HMM + IPTc                                       
4 clusters                                        
500 children under 10 years 
Primary end point :Malaria incidence (n= 500 ) 
♦^ĞĐŽŶĚĂƌǇĞŶĚƉŽŝŶƚƐ(n= 438 )
Randomized:           
8 communities 
HMM+IPTc (n= 500) 
HMM (n= 500) 
Not avalaible at baseline 
survey (n=10) 
Received IPTc in October (n=497)     
Not avalaible in October 2010 (n=03) 
Received IPTc in November (n= 500) 
HMM (n= 413) 
HMM+IPTc (n= 438) 
Enrollment 


	
         T
ȋί͙͕͜Ȍ

 
Figure 1 Trial profile:
1Two children in the HMM group were not seen by the CHWs during the second week of home visit.
2One child in the
HMM + IPTc group was not seen during the first week of follow up and two during the second week.
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the end of the transmission season
At the end of the malaria transmission season, 28 chil-
dren (3.3%) were found with P. falciparum. A propor-
tion of 4.6% (95% CI [2.5-6.6]) children in the HMM
group had asexual P. falciparum (any density) compared
with 2.1% (95% CI [0.7-3.3]) in the HMM + IPTc group.
The proportion of children with P. falciparum
parasitaemia at any density, was significantly lower in
the HMM + IPTc group (OR = 0.43 (95% CI [0.19-
0.95]); p =0 . 0 3 ) ,t h u sI P T c+H M Mh a dap r o t e c t i v e
efficacy against P. falciparum parasitaemia (at any den-
sity) of 57% (95% CI [5%-81%]).
Children with parasitaemia at a density > 1,000 para-
sites/μL at the end of the transmission season, repre-
sented 3.39% and 1.37% in the HMM and HMM + IPTc
Table 1 Baseline characteristics of children in the two groups
Interventions
Parameters HMM+IPTc HMM
Number of children 500 500
Number of clusters 04 04
Mean cluster size (range) 133 (130-145) 120 (102-145)
Age group
Children under 5 years, % 57.4 (287/500) 50 (250/500)
Children aged from 5 to 10 years, % 42.6 (213/500) 50 (250/500)
Gender, % of male 45.2 (226/500) 51.6(258/500)
P. falciparum carriage, % 11.2 (56/500) 9.4 (47/500)
Moderate anaemia, % (Hb between 11 and 8 g/dl) 58 (290/500) 56.4(282/500)
Severe anaemia (Hb * < 8 g/dl), % 21 (105/500) 24.8(124/500)
Stunting (HAZ < -2SD**), % 46.4 (232/500) 41.2 (206/500)
Bed net usage, % 95.8 (479/500) 95.4 (477/500)
*Hb haemoglobin; HAZ height for age z score
Figure 2 Kaplan-Meier plot comparing time to first episode of malaria attack defined as fever (> 37.5°C) and positive RDT, between
the two groups.
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0.05) resulting in a protective efficacy at 60% (95% CI
[04%-84%]) (Table 3).
Impact of the interventions on anaemia prevalence at the
end of the transmission season
Mean Hb concentration among children less than 10
years of age at the end of the malaria transmission sea-
son was 10.4 ± 1.98 g/dl in the HMM + IPTc group
and 10.2 ± 1.8 g/dl in the HMM group (p = 0.07). Pro-
portion of anaemic children (hb < 11 g/dl) at the end of
the transmission season was 54.11% in HMM + IPTc
group, while anaemic children represented 60.3% in the
HMM group (p = 0.06). In a logistic regression analysis
with robust standard errors, HMM + IPTc showed a
significant protective effect against anaemia (adjusted
Odds Ratio (aOR): 0.59 (95% CI [0.42-0.82]); p =0 . 0 2 5 .
The protective efficacy of HMM + IPTc in reducing
anaemia among children under 10 years was estimated
in this study at 41% (95% CI 95 [18%-58%]).
Anaemia was also significantly associated with P. falci-
parum carriage at the end of the transmission season,
(aOR = 2.57; 95% CI [1.1-6.70]; p = 0.026), stunting
(aOR = 2.97; 95% CI [2.08-4.23]; p = 0.001), age range
from two to 5 years (aOR = 0.14; 95% CI [0.08-0.25]; p
= 0.001) and age above 5 years (aOR = 0.04; 95% CI
[0.02-0.07]; p = 0.001) (Table 4).
Discussion
Malaria remains a major public health problem in
Africa, despite the decline in malaria incidence reported
by most African countries in recent years [20]. Early
case detection and prompt effective treatment with ACT
are essential tools for malaria control. Intermittent Pre-
ventive Treatment (IPT) is a new approach aiming at
reducing malaria morbidity and mortality. IPT is recom-
mended by the WHO for pregnant women and infants.
In children, the strategy is still debated and several stu-
dies are in progress [7-9].
This study assessed the potential benefit of combining
home based management of malaria with IPTc in an
area with high coverage of ITNs. The trial, conducted in
a rural area in Senegal, where malaria is highly seasonal,
showed that combination of IPTc and HMM can pro-
vide substantial benefit in reducing malaria. Indeed,
malaria incidence was lower in villages where HMM
was combined with IPTc compared to villages with only
HMM strategy. P. falciparum carriage at the end of the
transmission season was significantly lower in commu-
nities assigned to IPTc + HMM. No severe malaria
c a s e sw e r en o t e di nt h eH M M+I P T ca r m ,w h i l ef i v e
severe malaria cases were registered in the HMM arm;
thus the combination of IPTc and HMM can provide
substantial benefit in reducing occurrence of severe
malaria cases. The combined interventions also provided
Table 2 Impact of IPTc combined to HMM on malaria incidence in the two groups
Malaria incidence Rate/100 person-month
(95% CI)
Unadjusted IRR (95%
CI)
Adjusted IRR
(95% CI)
Protective efficacy (%)
(95% CI)
p
value*
Interventions
HMM 35.5 [25.0-50.3] 1 1
HMM + IPTc 07.1 [1.1- 9.5] 0.20 [0.04-1.0] 0.21[0.04-0.90] 79 [10; 96] 0.04
Gender
Female 21.0 [11.1-44.3] 1 1
Male 22.4 [11.6-48.3] 1.06 [0.62-1.84] 1.18 [0.74-1.86] -18[-86;26] 0.48
Age groups
1 years 17.3 [10.1-32.8] 1 1
[2 - 5 years] 28.5 [13.8-66.3] 1.62 [0.84-3.10] 1.50[0.85-2.65] -50[-165;15] 0.16
[6- 10 years] 17.4 [09.8-32.8] 1.0[0.74-1.34] 0.98[0.74-1.27] 2 [-27; 26] 0.85
HMM home-based management; HMM+IPTc home-based management+intermitent preventive treatment; IRR incidence rate ratio. Intraclass correlation
coefficients for Gender:0.01, age group:0.007. *All p value are adjusted for clustering by robust standard errors.
Table 3 Impact of interventions on malaria parasitaemia at the end of the transmission season
HMM (n = 413) HMM + IPTc (438) OR (95% CI) Protective efficacy (%) p value
P. falciparum parasitaemia
> 1,000 parasite/μL 14 (3.39%) 6 (1.37%) 0.40 [0.16 - 0.96] 60% [04 - 84] 0.05
any density 19 (4.60%) 9 (2.05%) 0.43[0.19-0.95] 57% [05 - 81] 0.03
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anaemia in children less than 10 years of age.
These results are consistent with data from other
trials. Tagbor et al., in a randomized controlled trial
conducted in children under 5 years in Ghana, demon-
strated that combining IPTc with HMM can signifi-
cantly reduce the incidence of malaria presumptive
fevers [21]. Another trial in the Gambia [17] showed a
reduction in the incidence of malaria in children under
5 years of age, when HMM is combined with IPT.
T h ee x p a n s i o no fm a l a r i ac ontrol measures at com-
munity level has been recommended by the WHO, in
order to accelerate malaria elimination [4]. Malaria elim-
ination will require the use of combination of interven-
tions [17], and this study showed that community health
workers can play an important role in scaling up anti-
malarial interventions and even contribute to the
malaria elimination process.
The study showed that combining HMM to IPTc in
an area with high coverage of ITN (95%) will provide
additional benefit in reducing malaria burden. The high
coverage of ITN in the study area means that study par-
ticipants had access to two or three interventions
(HMM and ITNs or HMM, IPTc, ITNs). Thus, a third
arm with only ITNs use would be appropriate to better
understand the effect on malaria burden of several anti-
malarial interventions. In other trials, conducted in Bur-
kina Faso [22] and Mali, [23] IPTc showed a high level
of protective efficacy against symptomatic malaria,
severe malaria, as well as moderate and severe anaemia
in children less than 5 years sleeping under ITNs. It
thus appears that IPTc would provide a valuable contri-
bution in reducing malaria by itself, or integrated with
other intervention strategies, in areas with highly seaso-
nal malaria [24].
The combination of IPTc and HMM was effective in
reducing the magnitude of malaria and anemia in chil-
dren less than 10 years. Although combined malaria
control strategies at community level are likely to reduce
malaria burden drastically, there are however, limited
information on how the resultant drug pressure (IPTc
drugs, ACT) may impact existing drug resistance. Con-
sequently, it is important to monitor drug resistance
while scaling up anti-malarial interventions at commu-
nity level.
Although HMM + IPTc showed a significant protec-
tive effect against anaemia, the prevalence of anaemia at
the end of the transmission season was still high. Anae-
mia was closely associated with P. falciparum carriage
and stunting. It is thus important to implement commu-
nity-based interventions to reduce anaemia among chil-
dren in rural areas, to complement interventions against
malaria, and malaria related anaemia. These interven-
tions could include, among other things, strengthening
and improving children’s nutritional status and investi-
gating for other possible causes of anaemia.
Conclusion
Combining IPTc and HMM can provide significant
additional benefit in preventing clinical episodes of
Table 4 Impact of interventions on anaemia prevalence at the end of the transmission season
Anaemia (Hb inf 11 g/dl)
Participants (%) OR (95% CI) aOR (95% CI) Protective efficacy (%) 95% CI p value
Interventions
HMM (n = 411) 248 (60.3) 1 1
HMM+IPTc (n = 438) 237 (54.1) 0.77[0.59 -1.02] 0.59[0.37-0.93] 41%[18;58] 0.025
Gender
Female (n = 398) 213 (53.5) 1 1
Male (451) 272(60.3) 1.32[1.01-1.73] 1.19[0.80-1.75] -19%[-75;20] 0.35
P. falciparum carriage
No (n = 821) 464 (56.5) 1 1
Yes (n = 28) 21 (75.0) 2.30[0.83-6.37] 2.56[1.12-5.85] -156%[-485;-12] 0.026
Stunting (HAZ < -2SD)
No (n = 546) 265 (48.53) 1 1
Yes (n = 305) 220 (72.13) 2.72 [1.86-3.98] 2.97[2.41-3.66] -197[-323;-108] 0.001
Age groups
Under 2 years n = 179) 162 (90.5) 1 1
[2-5 years](n = 374) 233 (62.30) 0.17[0.09-0.31] 0.14[0.08-0.24] 86%[76;92] 0.001
[5-10 years] (n = 296) 88 (29.73) 0.04[0.02-0.08] 0.04[0.02-0.07] 96%[93;98] 0.001
Goodness of fit test: Hosmer Lemeshow, Chi 2 (8df) = 7,36, p = 0,49. *aOR adjusted odds ratio; OR odds ratio. Intra-class correlation coefficients for each outcome
were as follows: age:0.02, Gender:0.001, stunting:0.08, slide microscopy positive:0.011. All p values are adjusted for clustering by robust standard errors.
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Page 8 of 9malaria as well as anaemia among children in Senegal.
IPTc would provide a valuable contribution in reducing
malaria, by itself or integrated with other intervention
strategies, in areas with highly seasonal malaria.
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